Screener
Relay Therapeutics, Inc. RLAY Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s total liabilities?
- Relay Therapeutics, Inc. (RLAY) reported total liabilities of $77.45M in Q2 2026.
- How has Relay Therapeutics, Inc.'s total liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s total liabilities increased by 22.6% year-over-year, from $63.18M to $77.45M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total liabilities has grown at a 8.2% compound annual growth rate (CAGR), from $36.54M to $54.27M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Relay Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude